Aytu BioPharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2011 | $-64.8K | $-64.8K | — | — |
| FY2012 | $-37.8K | $-37.8K | — | — |
| FY2013 | $-37.7K | $-37.7K | — | — |
| FY2014 | $-5.5M | $-5.5M | $9.3K | $499.7K |
| FY2015 | $-6.6M | $-6.6M | $0 | $1.0M |
| FY2016 | $-10.7M | $-10.9M | $252.9K | $902.9K |
| FY2017 | $-13.8M | $-13.9M | $111.6K | $2.5M |
| FY2018 | $-15.9M | $-16.0M | $74.7K | $596.9K |
| FY2019 | $-13.8M | $-13.9M | $59.8K | $1.0M |
| FY2020 | $-28.4M | $-28.4M | $0 | $1.1M |
| FY2021 | $-26.0M | $-28.3M | $2.3M | $3.6M |
| FY2022 | $-28.8M | $-28.8M | $0 | $5.2M |
| FY2023 | $-5.1M | $-5.1M | — | $6.0M |
| FY2024 | $-1.4M | $-1.7M | $329.0K | $2.4M |
| FY2025 | $-1.9M | $-2.2M | $228.0K | $576.0K |
| FY2026 | $3.3M | $3.3M | $29.0K | $691.0K |